Atlas Trials

Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients

Clinical trial NCT04573153 · TERMINATED

Trial details

NCT number
NCT04573153
Sponsor
ScandiBio Therapeutics AB
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-09-21
Primary completion
2022-05-05
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.